The Ohio Classic Interviews: Raymond Guns: CRO: Dope CFO

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Related Posts

HCN NECANN Interviews: Rick Laneve: Founder & CEO of Accounting Buds
High Finance with Peter Su ft. Marc Hauser: Founder: Cannabis Musings
High Finance with Peter Su ft. Kathryn Tucker: Director of Advocacy: National Psychedelics Association
High Finance with Peter Su ft. Frank Colombo: Managing Director: Viridian Capital Advisors
MJBizCon25 Interviews: Seth Yakatan: CEO: Katan Associates International

Latest News

Compass Completes FDA Application for COMP360

November 10th, 2026|

LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...

Vireo Growth Reports Q3 2026 Financial Results

November 10th, 2026|

MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...

Vireo Completes FLUENT Acquisition

November 10th, 2026|

MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...